GLPG News

Galapagos Creates New Subscription Right Plan

GLPG

Mechelen, Belgium; August 7, 2025, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its  Board of Directors created 1,800,000 subscription rights under a new subscription right plan.

August 7, 2025Capital
Read more →

Galapagos Announces New Data From ATALANTA-1 Study Of Investigational CAR-T Candidate GLPG5101

GLPG

May 14, 2025
Read more →

Galapagos Re-Evaluates Proposed Separation Amid Regulatory And Market Shifts, Explores Strategic Alternatives For Cell Therapy Business; Henry Gosebruch Named Galapagos CEO

GLPG

May 13, 2025
Read more →

Galapagos Q1 2025 GAAP EPS $(2.47) Down From $1.52 YoY, Sales $78.867M Up From $67.805M YoY

GLPG

April 23, 2025
Read more →

Galapagos CFO And COO Thad Huston To Depart August 1, 2025; Company To Name New CFO In Coming Months

GLPG

April 15, 2025
Read more →

Galapagos Receives Transparency Notification And 13D Filing From Tang Capital That It Holds 7.5% Of Total Outstanding Shares Of The Company

GLPG

February 17, 2025
Read more →

Morgan Stanley Downgrades Galapagos to Underweight, Lowers Price Target to $22

GLPG

February 14, 2025
Read more →

Galapagos Q4 EPS $0.30, Sales $80.58M (Converted To USD)

GLPG

February 12, 2025
Read more →

Galapagos Intends To Separate Into Two Publicly Traded Companies And To Establish SpinCo With ~€2.45B In Current Cash

GLPG

February 12, 2025
Read more →

Galapagos FY24 EPS €1.12 Down From €3.21 YoY; Revenue €275.6M Up From €239.7M YoY

GLPG

February 12, 2025
Read more →

RBC Capital Maintains Sector Perform on Galapagos, Lowers Price Target to $30

GLPG

November 1, 2024
Read more →

Where Galapagos Stands With Analysts

GLPG

Analysts have provided the following ratings for Galapagos (NASDAQ:GLPG) within the last quarter:

September 9, 2022
Read more →

Morgan Stanley Downgrades Galapagos to Equal-Weight, Lowers Price Target to $61

GLPG

September 9, 2022
Read more →